Stephen N. Birrell
Memorial Hospital of South Bend
7 Papers
168 Citations
Stephen N. Birrell is an academic researcher from Memorial Hospital of South Bend. The author has contributed to research in topics: Cancer & Androgen. The author has an hindex of 6, co-authored 7 publications. Previous affiliations of Stephen N. Birrell include Flinders Medical Centre.
Chat about Author
Papers
Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer
R. E. Hall,James O. Aspinall,David J. Horsfall,Stephen N. Birrell,Jacqueline M. Bentel,R. L. Sutherland,Wayne D. Tilley +6 more
TL;DR: Although apo-D expression is androgen regulated in human breast cancer cell lines in vitro, its expression in primary breast cancers may be regulated by other factors, which suggests that the receptor may be involved in tumour responsiveness or in abnormal responses to endocrine therapies.
75
Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.
TL;DR: PSA and GCDFP-15 immunoreactivity was dependent on the presence of AR, but not ER or PR in primary breast tumours, and unrelated to age, ER and PR status and axillary lymph node involvement.
58
Testosterone Undecanoate Treatment Reduces Joint Morbidities Induced by Anastrozole Therapy in Postmenopausal Women with Breast Cancer: Results of a Double-Blind, Randomized Phase II Trial.
TL;DR: This study has demonstrated for the first time that testosterone replacement may be a viable option in the management of AI-induced arthralgia, tenosynovitis and arthritis with good tolerability and safety, without adversely reducing aromatase inhibitor efficacy.
17
A Case of Acute Colonic Pseudoobstruction in Pregnancy
TL;DR: It is shown that acute colonic pseudoobstruction can occur during pregnancy and may be successfully managed by colonoscopy as in this patient, and perforation is likely to occur if the caecum is dilated to a diameter between 9–12 cm.
14
Hormones and cancer: new insights, new challenges.
TL;DR: The Hormones and Cancer 2000 Conference was held from 3–7 November 2000 in Port Douglas, Australia.
7